Skip to main content
. 2022 Aug 27;17(11):4075–4078. doi: 10.1016/j.radcr.2022.07.091

Fig. 2.

Fig 2

(A) MR imaging after thrombectomy for in-stent occlusion demonstrating no opacification of the excluded left posterior communicating artery aneurysm (white arrow). (B) Interval MR imaging 4 months post treatment demonstrating interval partial re-opacification of the aneurysm while patient was on enoxaparin in addition to DAPT (white arrow). (C) DSA 6 months post treatment and 2 months after discontinuation of enoxaparin demonstrating interval re-thrombosis with continued opacification of the aneurysm base (white arrow).